HK Stock Market Move | SHANDONG XINHUA (00719) fell more than 3% after its performance results, with the net profit attributable to shareholders in the first three quarters dropping by 25.53% year-on-year.
Shandong Xinhua Pharmaceutical Co., Ltd. (00719) fell more than 3% after its performance results, as of the time of publication, it fell by 3.17% to 7.03 Hong Kong dollars, with a trading volume of 31.1625 million Hong Kong dollars.
SHANDONG XINHUA (00719) fell more than 3% after its performance, dropping by 3.17% to HK$7.03 as of the time of publication, with a turnover of HK$31.1625 million.
On the news front, on October 24, SHANDONG XINHUA released its performance for the nine months ending September 30, 2025. The operating income was RMB 6.763 billion, a year-on-year increase of 0.42%; the net profit attributable to shareholders of the listed company was RMB 2.56 billion, a year-on-year decrease of 25.53%; and the basic earnings per share were RMB 0.37.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


